April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA95
Academic Journal
The article investigates clinical and functional significance of Vitamin D receptor (VDR) polymorphisms in inflammatory bowel disease. For the study purpose genomic DNA was extracted from 218 inflammatory bowel disease (IBD) patient and also included ulcerative colitis, Crohn's disease (CD) and indeterminate colitis patients. It has been observed that VDR polymorphisms have downstream effects upon target gene expression and clinical significance in IBD. The Fok1 polymorphism has links to colitis associated colorectal neoplasia.


Related Articles

  • Interleukin-4 and interleukin-4 receptor gene polymorphisms in inflammatory bowel diseases. Klein, W; Tromm, A; Griga, T; Fricke, H; Folwaczny, C; Hocke, M; Eitner, K; Marx, M; Duerig, N; Epplen, J T // Genes & Immunity;Aug2001, Vol. 2 Issue 5, p287 

    Imbalances in the regulation of Th1 and Th2 lymphocytes are crucial in inflammatory bowel diseases. Interleukin-4 is secreted by Th2 lymphocytes and downregulates cytokine production from Th I lymphocytes. Functionally relevant polymorphisms have been described in the interleukin-4 and the...

  • The CC chemokine receptor 5 Δ32 mutation is not associated with inflammatory bowel disease (IBD) in NE England. Craggs, A; Welfare, M; Donaldson, P T; Mansfield, J C // Genes & Immunity;Apr2001, Vol. 2 Issue 2, p114 

    Inflammatory bowel disease (IBD) is a group of chronic inflammatory diseases of the gastrointestinal tract of unknown aetiology. Evidence of abnormalities in immune regulation and cytokine production in patients with IBD has led to investigations of various immuno-regulatory genes as potential...

  • Genetic Polymorphisms Associated With Inflammatory Bowel Disease Do Not Confer Risk for Primary Sclerosing Cholangitis. Karlsen, Tom H.; Hampe, Jochen; Wiencke, Kristine; Schrumpf, Erik; Thorsby, Erik; Lie, Benedicte A.; Broomé, Ulrika; Schreiber, Stefan; Boberg, Kirsten Muri // American Journal of Gastroenterology;Jan2007, Vol. 102 Issue 1, p115 

    OBJECTIVES: Approximately 80% of patients with primary sclerosing cholangitis (PSC) of Northern European origin have concurrent inflammatory bowel disease (IBD). The majority have ulcerative colitis, but there is also an association with Crohn's colitis. The pathogenetic link between PSC and IBD...

  • Contribution of NKX2-3 Polymorphisms to Inflammatory Bowel Diseases: A Meta-Analysis of 35358 subjects. XiaoCheng Lu; Linjun Tang; Kai Li; JinYu Zheng; Penglai Zhao; Yi Tao; Li-Xin Li // Scientific Reports;1/31/2014, p1 

    Polymorphisms in NKX2-3 gene have been inconsistently associated with Crohn's disease (CD) and ulcerative colitis (UC). To generate large-scale evidence on whether NKX2-3 polymorphisms are associated with CD or UC susceptibility we have conducted a meta-analysis of 17 studies involving 17329...

  • Vitamin D Deficiency Associated with Disease Activity in Patients with Inflammatory Bowel Diseases. Torki, Mehdi; Gholamrezaei, Ali; Mirbagher, Leila; Danesh, Manijeh; Kheiri, Sara; Emami, Mohammad; Emami, Mohammad Hassan // Digestive Diseases & Sciences;Oct2015, Vol. 60 Issue 10, p3085 

    Background: Evidence exists on the association between vitamin D deficiency and inflammatory bowel diseases (IBD).Aims: To investigate whether vitamin D level is associated with disease activity and quality of life in IBD patients.Methods: This...

  • Quantitative lymphatic vessel trait analysis suggests Vcam1 as candidate modifier gene of inflammatory bowel disease. Jurisic, G.; Sundberg, J. P.; Bleich, A.; Leiter, E. H.; Broman, K. W.; Buechler, G.; Alley, L.; Vestweber, D.; Detmar, M. // Genes & Immunity;Apr2010, Vol. 11 Issue 3, p219 

    Inflammatory bowel disease (IBD) is a chronic debilitating disease resulting from a complex interaction of multiple genetic factors with the environment. To identify modifier genes of IBD, we used an F2 intercross of IBD-resistant C57BL/6J-Il10−/− mice and IBD-susceptible...

  • Vitamin D and Inflammatory Bowel Disease. Ardesia, Marco; Ferlazzo, Guido; Fries, Walter // BioMed Research International;4/27/2015, Vol. 2015, p1 

    Vitamin D deficiency has been recognized as an environmental risk factor for Crohn’s disease since the early 80s. Initially, this finding was correlated with metabolic bone disease. Low serum 25-hydroxyvitamin D levels have been repeatedly reported in inflammatory bowel diseases together...

  • Epidemiology of Inflammatory Bowel Diseases in Iran and Asia; A Mini Review. Safarpour, Ali Reza; Hosseini, Seyed Vahid; Mehrabani, Davood // Iranian Journal of Medical Sciences;Jun2013 Supplement, Vol. 38, p140 

    The prevalence of inflammatory bowel diseases (IBDs) is set to stabilize in Western Europe and North America, as opposed to its increasing trend in developing countries in Asia. The epidemiology of IBDs in areas where the incidence and prevalence are relatively low provides an opportunity for...

  • Dynamics of vitamin D in patients with mild or inactive inflammatory bowel disease and their families. Grunbaum, Avigyle; Holcroft, Christina; Heilpern, Debra; Gladman, Stephanie; Burstein, Barry; Menard, Maryse; Al-Abbad, Jasim; Cassoff, Jamie; MacNamara, Elizabeth; Gordon, Philip H.; Szilagyi, Andrew // Nutrition Journal;2013, Vol. 12, p1 

    Background: 25(OH) vitamin D levels may be low in patients with moderately or severely active inflammatory bowel diseases (IBD: Crohn's disease and Idiopathic Ulcerative Colitis) but this is less clear in patients with mild or inactive IBD. Furthermore there is limited information of any family...


Read the Article


Sign out of this library

Other Topics